Takeda Pharmaceutical Company Limited (TAK)

Takeda Pharmaceutical Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 25, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	46,322	45,074	43,399	50,869	44,662	56,329
Market Cap Growth	-1.64%	3.86%	-14.68%	13.90%	-20.71%	17.61%
Enterprise Value	77,653	78,050	75,918	81,755	74,563	98,218
Last Close Price	14.65	14.87	13.38	15.36	12.87	15.79
PE Ratio	48.81	62.54	45.57	21.33	23.57	16.57
PS Ratio	1.49	1.47	1.54	1.68	1.52	1.95
PB Ratio	0.97	0.97	0.90	1.06	0.95	1.20
P/FCF Ratio	7.62	7.88	12.14	8.08	5.42	6.92
P/OCF Ratio	6.06	6.39	9.16	6.92	4.83	6.16
EV/Sales Ratio	2.50	2.55	2.69	2.70	2.54	3.40
EV/EBITDA Ratio	9.19	9.48	10.04	8.46	7.65	11.04
EV/EBIT Ratio	20.03	20.76	22.99	17.54	15.09	25.62
EV/FCF Ratio	12.77	13.65	21.23	12.99	9.06	12.07
Debt / Equity Ratio	0.73	0.73	0.75	0.77	0.85	0.98
Debt / EBITDA Ratio	3.97	3.96	4.57	3.79	4.07	5.16
Debt / FCF Ratio	5.53	5.94	10.10	5.81	4.81	5.64
Asset Turnover	0.30	0.31	0.29	0.30	0.27	0.25
Inventory Turnover	1.25	1.30	1.30	1.36	1.40	1.34
Quick Ratio	0.48	0.44	0.50	0.49	0.73	1.00
Current Ratio	1.16	1.01	1.11	0.97	1.21	1.53
Return on Equity (ROE)	1.87%	1.52%	2.12%	5.27%	4.24%	7.60%
Return on Assets (ROA)	2.31%	2.40%	2.15%	2.85%	2.88%	2.06%
Return on Capital (ROIC)	2.71%	2.84%	2.61%	3.57%	3.62%	2.59%
Return on Capital Employed (ROCE)	4.70%	4.80%	3.90%	5.40%	5.40%	3.80%
Earnings Yield	2.05%	1.60%	2.20%	4.69%	4.24%	6.04%
FCF Yield	13.13%	12.69%	8.24%	12.37%	18.44%	14.44%
Dividend Yield	3.70%	8.80%	9.29%	8.81%	11.52%	10.31%
Payout Ratio	91.86%	280.28%	199.34%	88.14%	123.30%	75.36%
Buyback Yield / Dilution	-1.18%	-1.58%	-0.67%	0.46%	-0.23%	-0.47%
Total Shareholder Return	2.52%	7.22%	8.62%	9.28%	11.29%	9.84%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q